Choong Ang Vaccine Laboratory Co. Ltd (072020) — Capital Reinvestment Ratio

Latest as of March 2026: 0.56x

Choong Ang Vaccine Laboratory Co. Ltd (072020) has a Capital Reinvestment Ratio of 0.56x as of March 2026, meaning it reinvests 1% of its operating cash flow (₩2.30 Billion) in capital expenditures (₩1.28 Billion). See how much free cash does Choong Ang Vaccine Laboratory Co. Ltd generate to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.56x
Capex / Operating Cash Flow

Operating Cash Flow

₩2.30 Billion
KRW

Capital Expenditures

₩1.28 Billion
KRW

Data as of

Mar 2026
Most recent filing

Choong Ang Vaccine Laboratory Co. Ltd Capital Reinvestment Ratio (2009–2025)

This chart tracks Choong Ang Vaccine Laboratory Co. Ltd's Capital Reinvestment Ratio across 16 annual periods.

Annual Capital Reinvestment Ratio for Choong Ang Vaccine Laboratory Co. Ltd (2009–2025)

Year-by-year Capital Reinvestment Ratio for Choong Ang Vaccine Laboratory Co. Ltd from 2009 to 2025. For live market cap and broader valuation context, see Choong Ang Vaccine Laboratory Co. Ltd (072020) total market value.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2025 0.76x ₩7.87 Billion ₩5.98 Billion ▲ +41.9%
2024 0.54x ₩13.40 Billion ₩7.17 Billion ▲ +254.5%
2023 0.15x ₩12.71 Billion ₩1.92 Billion ▼ -84.9%
2022 1.00x ₩7.09 Billion ₩7.10 Billion ▼ -19.3%
2021 1.24x ₩11.53 Billion ₩14.31 Billion ▼ -33.0%
2020 1.85x ₩8.32 Billion ₩15.40 Billion ▲ +129.0%
2019 0.81x ₩8.30 Billion ₩6.71 Billion ▼ -21.5%
2018 1.03x ₩5.71 Billion ₩5.89 Billion ▼ -40.8%
2017 1.74x ₩7.56 Billion ₩13.18 Billion ▲ +86.2%
2016 0.94x ₩7.71 Billion ₩7.22 Billion ▲ +205.4%
2015 0.31x ₩9.93 Billion ₩3.04 Billion ▼ -38.9%
2014 0.50x ₩6.67 Billion ₩3.35 Billion ▼ -79.2%
2012 2.41x ₩5.16 Billion ₩12.43 Billion ▲ +576.9%
2011 0.36x ₩4.94 Billion ₩1.76 Billion ▲ +0.0%
2010 0.36x ₩4.94 Billion ₩1.76 Billion ▼ -54.4%
2009 0.78x ₩5.26 Billion ₩4.11 Billion
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow